Pure Global
NCT06412809

Combine Land- and Water-Based Core and Lower Extremity Strength Training in Improving the Jump Performance Among Volleyball and Basketball Players

Combine Land- and Water-Based Core and Lower Extremity Strength Training in Improving the Jump Performance Among Volleyball and Basketball Players: A Randomized Controlled Trial
Mariano Marcos State University·ClinicalTrials.gov·otherRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Athletes
Drug/Device/Intervention
Combined Land- and Water-Based Exercise
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Mariano Marcos State University
Location
Batac, Philippines
Timeline & enrollment
Phase
N/A
Start date
Apr 26, 2024
End date
May 17, 2024
Enrollment
20 participants
Primary outcome

Vertical Jump,Countermovement Jump,Squat Jump

Summary

Given conflicting studies regarding the effect of land-based and water-based training on the
 jump performance of volleyball and basketball players, a randomized controlled trial is
 conducted. This study hypothesizes that combined land- and water-based core and lower
 strength training significantly increase jump performance of volleyball and basketball
 players in comparison to either land- and/or water-based training alone.

ICD-10 classifications
Examination for participation in sportStriking against or struck by sports equipmentRoutine general health check-up of sports teams
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06412809
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06412809 through Pure Global AI's free database. This phase not specified trial is sponsored by Mariano Marcos State University and is currently Recruitment Completed. The study focuses on Athletes. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.